Aurorium U.K. Limited is seeking to divest 100% of the equity shares of Aurorium India Private Limited (AIPL), presenting a strategic acquisition opportunity within the Vapi chemical cluster, Gujarat. This mandate offers qualified buyers access to a premium manufacturing platform in one of India’s most established industrial zones, without the time, cost, and regulatory complexity associated with a greenfield setup.
The opportunity is positioned for organisations seeking speed to market, brownfield expansion, operational continuity, or an efficient entry into India’s specialty chemicals and allied manufacturing ecosystem.
Vapi is one of India’s premier chemical and pharmaceutical manufacturing zones, offering strong road, rail, and port connectivity, a mature supply-chain ecosystem, access to skilled technical talent, and established regulatory infrastructure. This makes the site especially attractive for buyers seeking a strategically located and operationally credible industrial platform.
The transaction is being led through a structured process beginning with Expression of Interest (EOI), followed by NDA execution, access to the Information Memorandum and Virtual Data Room, submission of a Non-Binding Offer, and participation in a competitive digital auction for shortlisted parties.
Interested organisations may initiate a preliminary discussion to assess strategic fit, transaction relevance, and process alignment. Detailed documents, commercial parameters, and transaction-specific information will be shared only with qualified parties through a structured and confidential engagement process.
Sekhar Rajagopalan serves as the single point of contact for all discussions, expressions of interest, clarification requests, and process coordination.
